↓ Skip to main content

Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study

Overview of attention for article published in Drugs - Real World Outcomes, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
47 Mendeley
Title
Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study
Published in
Drugs - Real World Outcomes, February 2019
DOI 10.1007/s40801-019-0147-3
Pubmed ID
Authors

Tinashe Mudzviti, Tinei Shamu, Cleophas Chimbetete, Tilda Munengerwa, Sandra Bote, Margaret Pascoe

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 21%
Student > Bachelor 5 11%
Other 4 9%
Researcher 4 9%
Student > Ph. D. Student 4 9%
Other 6 13%
Unknown 14 30%
Readers by discipline Count As %
Medicine and Dentistry 17 36%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 2 4%
Immunology and Microbiology 2 4%
Other 4 9%
Unknown 16 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2019.
All research outputs
#15,560,927
of 23,128,387 outputs
Outputs from Drugs - Real World Outcomes
#113
of 188 outputs
Outputs of similar age
#271,903
of 447,836 outputs
Outputs of similar age from Drugs - Real World Outcomes
#2
of 2 outputs
Altmetric has tracked 23,128,387 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 188 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,836 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.